about
Genome-wide association analyses identify 18 new loci associated with serum urate concentrationsTetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive ratsThe current role of thiazolidinediones in diabetes management.Transcriptional targets in adipocyte biologyPioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.The role of incretins in glucose homeostasis and diabetes treatment.Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study.Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury.Managing type 2 diabetes: balancing HbA1c and body weight.Thiazolinedione treatment in PCOS--an update.PPAR-γ agonism for cardiovascular and renal protection.Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism.Peroxisome proliferator-activated receptors and atherosclerosis.Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesis.Differential modulation of farnesoid X receptor signaling pathway by the thiazolidinedionesHepatic inflammation and insulin resistance in pre-diabetes - further evidence for the beneficial actions of PPAR-gamma agonists and a role for SOCS-3 modulation.Rosiglitazone regulates IL-6-stimulated lipolysis in porcine adipocytes.Effects of rosiglitazone on proliferation and differentiation of duck preadipocytes.Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise Exposure
P2860
Q24620065-AE1901CB-5806-4E2F-8293-310D61414D31Q28565662-07DC762C-8B71-42C3-812E-7459FC1454DBQ30250347-AC52CD4D-51E8-4C17-BAAA-9F6D8F60C07FQ34192987-DB69936D-CD84-4616-85FF-4A5DEB79D22CQ34442391-DC042E65-B2C0-4232-A94D-86F587D62CF1Q34901533-B21010C1-433D-449D-ACF0-5509DAF9896FQ36058654-FDA064CB-35CB-417B-8277-9A9DE1BAFEBFQ37306331-5B504550-35F4-4D93-9BDE-61895C5A9952Q37361545-343733B7-895E-441A-8B3D-F72E4ECCB833Q37750274-6233DF54-2D6E-4A42-B0AB-A78DDADF50BEQ37763184-71D1CFF6-063F-4D12-BD10-5BA5FBCCD138Q37788729-AABA39BE-10EA-479D-BE2C-46A54EEECE73Q37857866-74774C78-7DB1-48A4-B693-A485913678EAQ37861955-8EBC2735-7DAB-4F48-AF71-CEAC32313D51Q38077284-E036039A-B78B-4175-A75B-29824A6FF88BQ39860554-12E4DB00-6C03-48E8-A836-D1F1B81217E3Q42026662-528CB1D9-B4EA-4A01-B1B3-D0688762FB54Q42870043-C5A80CBF-EC36-4A4C-894B-4DFE896F9C46Q50282554-14AF312B-3F7F-4F8B-80AA-92C5A7C6F17FQ54518829-F4FC4FBE-A152-4164-8143-1879E00694ABQ57817598-2E032815-8A15-4487-91A7-B204B95C53C5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pleiotropic effects of thiazolidinediones.
@en
Pleiotropic effects of thiazolidinediones.
@nl
type
label
Pleiotropic effects of thiazolidinediones.
@en
Pleiotropic effects of thiazolidinediones.
@nl
prefLabel
Pleiotropic effects of thiazolidinediones.
@en
Pleiotropic effects of thiazolidinediones.
@nl
P2093
P2860
P1476
Pleiotropic effects of thiazolidinediones.
@en
P2093
D P Mikhailidis
E N Liberopoulos
M S Elisaf
P2860
P304
P356
10.1517/14656566.9.7.1087
P407
P577
2008-05-01T00:00:00Z